Does GOLIMUMAB Cause Intentional product use issue? 2,616 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 2,616 reports of Intentional product use issue have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 3.8% of all adverse event reports for GOLIMUMAB.
2,616
Reports of Intentional product use issue with GOLIMUMAB
3.8%
of all GOLIMUMAB reports
1,041
Deaths
1,323
Hospitalizations
How Dangerous Is Intentional product use issue From GOLIMUMAB?
Of the 2,616 reports, 1,041 (39.8%) resulted in death, 1,323 (50.6%) required hospitalization, and 1,259 (48.1%) were considered life-threatening.
Is Intentional product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 2,616 reports have been filed with the FAERS database.
What Other Side Effects Does GOLIMUMAB Cause?
Drug ineffective (17,959)
Rheumatoid arthritis (12,272)
Pain (11,443)
Fatigue (9,626)
Off label use (8,764)
Alopecia (8,394)
Rash (8,331)
Joint swelling (8,264)
Arthralgia (7,968)
Abdominal discomfort (7,902)
What Other Drugs Cause Intentional product use issue?
INFLIXIMAB (11,028)
RITUXIMAB (9,602)
INFLIXIMAB-DYYB (7,549)
TOCILIZUMAB (5,078)
METHOTREXATE (4,087)
PREDNISONE (3,961)
ABATACEPT (3,693)
ADALIMUMAB (3,557)
NIVOLUMAB (3,297)
LEFLUNOMIDE (3,280)
Which GOLIMUMAB Alternatives Have Lower Intentional product use issue Risk?
GOLIMUMAB vs GOLODIRSEN
GOLIMUMAB vs GONADORELIN
GOLIMUMAB vs GONADOTROPHIN, CHORIONIC
GOLIMUMAB vs GOSERELIN
GOLIMUMAB vs GRAMICIDIN